Our public health programs are failing the children who need them most. Together, Medicaid and the Children’s Health Insurance Program (CHIP) cover half of all children...
The Federal Trade Commission reached a proposed settlement with CVS Caremark, one of the largest pharmacy benefit managers in the U.S., over allegations the company artificially...
In a new study published in Nature Immunology titled, “Engineering NK and T cells with metabolite-sensing receptors to target solid tumors”, researchers from Stanford University have developed an approach...
A study led by Adelaide University scientists at the Centre for Cancer Biology (CCB) has uncovered a critical mechanism driving the growth and spread of glioblastoma (GBM)—one...
The prominent investor aims to merge its latest special purpose acquisition company with a Chinese biotech, according to a securities filing.
Pharmaceutical companies that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs that were the focus of the alleged violations...
Brian Murphy, a U.S. District Judge in Massachusetts, recently temporarily blocked key parts of RFK Jr.’s plan to change the U.S. childhood vaccine schedule. Judge Murphy...
Patrick Soon-Shiong, a controversial figure in the biotech industry, was harshly criticized by the U.S. Food and Drug Administration for making several false and misleading claims...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
Ocugen said it will take its gene therapy for a form of vision loss into a Phase 3 trial, after reporting mixed results on Tuesday from...